Clinical Trial Update: A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

This Phase 2 dose-finding trial of the investigational drug GSK1070806 in adults with moderate-to-severe atopic dermatitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• GSK1070806

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dermatitis, Atopic | Phase 2 | Status: TERMINATED